Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Karyopharm Therapeutics
Fierce Biotech
Karyopharm lays off 20% of staffers amid hunt for alternatives
At the end of last year, Karyopharm recorded an accumulated deficit of $1.6 billion, according to an annual report.
Gabrielle Masson
Jul 11, 2025 11:02am
With sales stagnating for Xpovio, Karyopharm slices staff by 20%
Aug 2, 2023 11:10am
Karyopharm hits FDA setback with Xpovio's cancer expansion bid
Mar 2, 2022 11:03am
Karyopharm plans FDA filing for Xpovio in endometrial cancer
Feb 9, 2022 8:46am
Karyopharm snags DLBCL nod for Xpovio
Jun 23, 2020 10:40am
Karyopharm's controversial Xpovio could see wider market
Mar 10, 2020 11:58am
